Literature DB >> 16043151

The combined free partial vastus lateralis with anterolateral thigh perforator flap reconstruction of extensive composite defects.

N A S Posch1, M A M Mureau, S J Flood, S O P Hofer.   

Abstract

Myocutaneous (MC) free flaps are useful for many reconstructive indications. Perforator flaps have become standard of care. The anterolateral thigh flap (ALT) donor site is popular. With the ALT flap varying sizes of vastus lateralis (VL) muscle can be harvested as a MC flap. The skin islands of these flaps have a great range of freedom when dissected on their perforator. It was hypothesised that the VL-ALT perforator flap would offer adequate tissue volume combining maximal freedom in planning with minimal donor site morbidity. From November 2001 to February 2003 a free partial VL with ALT perforator flap was used in 11 patients to reconstruct large defects. Indications for adding a muscular component were exposed bone, skull base, (artificial) dura, or osteosynthesis material, open sinuses, and lack of muscular bulk. Flaps were planned as standard ALT flaps, after which three types of dissection were performed: I. true MC flap; II. muscle flap with a skin island on one perforator, which could be rotated up to 180 degrees ; III. chimera skin perforator flap with muscle being harvested on a separate branch from the source vessel or on a side branch of the skin perforator. Mean skin size of the MC-ALT flaps was 131 cm2. Mean muscle part size of the MC-ALT flaps was 268 cm3. Muscular parts were custom designed for all defects. No total or partial flap failures were seen. Colour mismatch was seen in 6 of 8 patients, when skin was used in the facial area in this all white population. Excessive flap bulk was found in 8 of 11 patients at 6 weeks, however, only in 2 of 11 patients after 6 months. Patients were satisfied with the functional result (8 of 11 patients) as well as the cosmetic result of their reconstruction (7 of 11 patients). All less satisfied patients had received their flap for external facial skin reconstruction. Donor site morbidity was minimal. The combined free partial VL with ALT perforator flap proved valuable as a (chimera type) MC flap with maximal freedom of planning to meet specific reconstructive demands and minimal donor site morbidity.

Entities:  

Mesh:

Year:  2005        PMID: 16043151     DOI: 10.1016/j.bjps.2005.04.022

Source DB:  PubMed          Journal:  Br J Plast Surg        ISSN: 0007-1226


  6 in total

1.  [Combined latissimus dorsi-thoracodorsal artery perforator-transpositional free flap].

Authors:  B Del Frari; A H Schwabegger
Journal:  Unfallchirurg       Date:  2007-01       Impact factor: 1.000

2.  Perforator flap: A novel method for providing skin cover to lower limb defects.

Authors:  M K Mukherjee; M Alam Parwaz; B Chakravarty; V Langer
Journal:  Med J Armed Forces India       Date:  2012-08-15

3.  One plus one: Two free flaps from same donor thigh for simultaneous coverage of two different defects.

Authors:  Susmitha Bandi; Rayidi Venkata Koteswara Rao; Damalacheruvu Mukunda Reddy
Journal:  Indian J Plast Surg       Date:  2016 May-Aug

4.  [Modified pedicled anterolateral thigh myocutaneous flap for large full-thickness abdominal defect reconstruction].

Authors:  Dajiang Song; Zan Li; Xiao Zhou; Yixin Zhang; Xiaowei Peng; Bo Zhou; Chunliu Lü
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2019-10-15

5.  Single stage reconstruction of complex head and neck defects involving the skin with a single ALT flap: A ten year review.

Authors:  Umberto Caliceti; Rossella Sgarzani; Riccardo Cipriani; Stefano Cantore; Federico Contedini; Valentina Pinto; Chiara Gelati; Ottavio Piccin
Journal:  JPRAS Open       Date:  2019-11-04

6.  A neglected problem in the utilization of free anterolateral thigh flap toward reconstructing complicated wounds of extremities: the obliteration of deep dead space.

Authors:  Gao-Hong Ren; Da-Yong Xiang; Xiao-Hu Wu; Yun-Biao Chen; Runguang Li
Journal:  J Orthop Surg Res       Date:  2020-10-21       Impact factor: 2.359

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.